Effects of Pueraria mirifica gel on overactive bladder symptoms in postmenopausal wome
Phase 2
- Conditions
- Overactive bladder in menopausal women
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
No history of estrogen use in previous 3 month
- No history of medical treatment for OAB in previous 3 month
- No current UTI
- No postmenopausal bleeding with unknown diagnosis
- No contraindication for estrogen therapy such as breast cancer, ovarian cancer, VTE, active liver disease
Exclusion Criteria
- Patient deny
- Exist complication from Pueraria mirifica gel or placebo
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method OABSS at 12 week after intervention OABS score
- Secondary Outcome Measures
Name Time Method Quality of life after intervention at 12 week after intervention IIQ-7,Urethral maturation indexUrethral maturation at 12 week after intervention Urethral maturation indexUrethral maturation